Eggan Stephen M, Lewis David A
Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Cereb Cortex. 2007 Jan;17(1):175-91. doi: 10.1093/cercor/bhj136. Epub 2006 Feb 8.
Delta-9-tetrahydrocannabinol (Delta9-THC) has profound effects on higher cognitive functions, and exposure to Delta9-THC has been associated with the appearance or exacerbation of the clinical features of schizophrenia. These actions appear to be mediated via the CB1 receptor, the principal cannabinoid receptor expressed in the brain. However, the distribution of the CB1 receptor in neocortical regions of the primate brain that mediate cognitive functions is not known. We therefore investigated the immunocytochemical localization of the CB1 receptor in the brains of macaque monkeys and humans using antibodies that specifically recognize the N- or C-terminus of the CB1 receptor. In monkeys, intense CB1 immunoreactivity was observed primarily in axons and boutons. Across neocortical regions of the monkey brain, CB1-immunoreactive (IR) axons exhibited considerable heterogeneity in density and laminar distribution. Neocortical association regions, such as the prefrontal and cingulate cortices, demonstrated a higher density, and exhibited a unique laminar pattern of CB1-IR axons, compared with primary sensory and motor cortices. Similar regional and laminar distributions of CB1-IR axons were also present in the human neocortex. CB1-IR axons had more prominent varicosities in human tissue, but this difference appeared to represent a postmortem effect as similar morphological features increased in unperfused monkey tissue as a function of postmortem interval. In electron microscopy studies of perfused monkey prefrontal cortex, CB1 immunoreactivity was predominantly found in axon terminals that exclusively formed symmetric synapses. The high density, distinctive laminar distribution, and localization to inhibitory terminals of CB1 receptors in primate higher-order association regions suggests that the CB1 receptor may play a critical role in the circuitry that subserves cognitive functions such as those that are disturbed in schizophrenia.
Δ⁹-四氢大麻酚(Δ⁹-THC)对高级认知功能有深远影响,接触Δ⁹-THC与精神分裂症临床特征的出现或加重有关。这些作用似乎是通过CB1受体介导的,CB1受体是大脑中表达的主要大麻素受体。然而,CB1受体在灵长类动物大脑中介导认知功能的新皮质区域的分布尚不清楚。因此,我们使用特异性识别CB1受体N端或C端的抗体,研究了食蟹猴和人类大脑中CB1受体的免疫细胞化学定位。在猴子中,主要在轴突和突触小体中观察到强烈的CB1免疫反应性。在猴脑的新皮质区域,CB1免疫反应性(IR)轴突在密度和层状分布上表现出相当大的异质性。与初级感觉和运动皮质相比,新皮质联合区域,如前额叶和扣带回皮质,显示出更高的密度,并呈现出独特的CB1-IR轴突层状模式。人类新皮质中也存在类似的CB1-IR轴突区域和层状分布。CB1-IR轴突在人类组织中有更明显的膨体,但这种差异似乎代表了一种死后效应,因为在未灌注的猴组织中,类似的形态特征会随着死后间隔时间的延长而增加。在灌注猴前额叶皮质的电子显微镜研究中,CB1免疫反应性主要存在于仅形成对称突触的轴突终末。灵长类动物高级联合区域中CB1受体的高密度、独特的层状分布以及定位于抑制性终末,表明CB1受体可能在维持认知功能(如精神分裂症中受干扰的那些功能)的神经回路中起关键作用。